Summary of findings table ‐ Convalescent plasma vs human immunoglobulin
Grades 3 and 4 adverse events ‐ not reported · individuals with moderate to severe disease
The review found no eligible studies for this question.
1 finding from 1 review
- Convalescent plasma for people with COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found